Literature DB >> 30951810

Synthetic biology approaches for chromosomal integration of genes and pathways in industrial microbial systems.

Lei Li1, Xiaocao Liu2, Keke Wei3, Yinhua Lu4, Weihong Jiang5.   

Abstract

Industrial biotechnology is reliant on native pathway engineering or foreign pathway introduction for efficient biosynthesis of target products. Chromosomal integration, with intrinsic genetic stability, is an indispensable step for reliable expression of homologous or heterologous genes and pathways in large-scale and long-term fermentation. With advances in synthetic biology and CRISPR-based genome editing approaches, a wide variety of novel enabling technologies have been developed for single-step, markerless, multi-locus genomic integration of large biochemical pathways, which significantly facilitate microbial overproduction of chemicals, pharmaceuticals and other value-added biomolecules. Notably, the newly discovered homology-mediated end joining strategy could be widely applicable for high-efficiency genomic integration in a number of homologous recombination-deficient microbes. In this review, we explore the fundamental principles and characteristics of genomic integration, and highlight the development and applications of targeted integration approaches in the three representative industrial microbial systems, including Escherichia coli, actinomycetes and yeasts.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR-Cas; Chromosomal integration; Homology-mediated end joining; Industrial biotechnology; Site-specific recombination; Synthetic biology

Year:  2019        PMID: 30951810     DOI: 10.1016/j.biotechadv.2019.04.002

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  8 in total

Review 1.  Recent advances in the application of multiplex genome editing in Saccharomyces cerevisiae.

Authors:  Zi-Xu Zhang; Ling-Ru Wang; Ying-Shuang Xu; Wan-Ting Jiang; Tian-Qiong Shi; Xiao-Man Sun; He Huang
Journal:  Appl Microbiol Biotechnol       Date:  2021-04-27       Impact factor: 4.813

Review 2.  Advances and prospects in metabolic engineering of Escherichia coli for L-tryptophan production.

Authors:  Shuai Liu; Jian-Zhong Xu; Wei-Guo Zhang
Journal:  World J Microbiol Biotechnol       Date:  2022-01-06       Impact factor: 3.312

Review 3.  Recent Advances in Synthetic Biology Approaches to Optimize Production of Bioactive Natural Products in Actinobacteria.

Authors:  Lei Li; Xiaocao Liu; Weihong Jiang; Yinhua Lu
Journal:  Front Microbiol       Date:  2019-11-05       Impact factor: 5.640

4.  Metabolomic Alterations Do Not Induce Metabolic Burden in the Industrial Yeast M2n[pBKD2-Pccbgl1]-C1 Engineered by Multiple δ-Integration of a Fungal β-Glucosidase Gene.

Authors:  Lorenzo Favaro; Lorenzo Cagnin; Laura Corte; Luca Roscini; Fabio De Pascale; Laura Treu; Stefano Campanaro; Marina Basaglia; Willem H van Zyl; Sergio Casella; Gianluigi Cardinali
Journal:  Front Bioeng Biotechnol       Date:  2019-11-28

5.  Optimized gene expression from bacterial chromosome by high-throughput integration and screening.

Authors:  Tatyana E Saleski; Meng Ting Chung; David N Carruthers; Azzaya Khasbaatar; Katsuo Kurabayashi; Xiaoxia Nina Lin
Journal:  Sci Adv       Date:  2021-02-12       Impact factor: 14.136

Review 6.  Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing.

Authors:  Song Zhang; Jiangtao Shen; Dali Li; Yiyun Cheng
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

7.  Repurposing CRISPR RNA-guided integrases system for one-step, efficient genomic integration of ultra-long DNA sequences.

Authors:  Zhou-Hua Cheng; Jie Wu; Jia-Qi Liu; Di Min; Dong-Feng Liu; Wen-Wei Li; Han-Qing Yu
Journal:  Nucleic Acids Res       Date:  2022-07-22       Impact factor: 19.160

Review 8.  Recent Advances in Heterologous Synthesis Paving Way for Future Green-Modular Bioindustries: A Review With Special Reference to Isoflavonoids.

Authors:  Moon Sajid; Shane Ramsay Stone; Parwinder Kaur
Journal:  Front Bioeng Biotechnol       Date:  2021-07-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.